Log in to save to my catalogue

Identified a novel prognostic model of HCC basing on virus signature for guiding immunotherapy

Identified a novel prognostic model of HCC basing on virus signature for guiding immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2817421759c24ee385cf614547061850

Identified a novel prognostic model of HCC basing on virus signature for guiding immunotherapy

About this item

Full title

Identified a novel prognostic model of HCC basing on virus signature for guiding immunotherapy

Publisher

New York: Springer US

Journal title

Discover. Oncology, 2024-10, Vol.15 (1), p.551-17, Article 551

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Oncolytic viral immunotherapy is a cancer treatment that uses native or genetically modified viruses that selectively replicate and destroy tumor cells. In this study, we aimed to construct a virus-based prognostic model for risk assessment and prognosis prediction in patients with hepatocellular carcinoma (HCC) and determine the most appropriate v...

Alternative Titles

Full title

Identified a novel prognostic model of HCC basing on virus signature for guiding immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2817421759c24ee385cf614547061850

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2817421759c24ee385cf614547061850

Other Identifiers

ISSN

2730-6011

E-ISSN

2730-6011

DOI

10.1007/s12672-024-01427-w

How to access this item